{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:44:38Z","timestamp":1775097878629,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bulcan.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T23:21:10Z","timestamp":1463527270000},"page":"786-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cons\u00e9quences de la diminution de la masse musculaire sur la tol\u00e9rance des traitements anticanc\u00e9reux"],"prefix":"10.1016","volume":"103","author":[{"given":"St\u00e9phanie","family":"Chemama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Raynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2016.04.002_bib0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"Du Bois","year":"1916","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0180","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0185","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1200\/JCO.2014.55.4261","article-title":"Incorporating biomarkers into cancer and aging research","volume":"32","author":"Hubbard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0190","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/PPO.0000000000000068","article-title":"Understanding frailty in cancer patients","volume":"20","author":"Baijal","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0200","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","article-title":"Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?","volume":"34","author":"Andreyev","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0205","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P","article-title":"The predictive value of body protein for chemotherapy-induced toxicity","volume":"88","author":"Aslani","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0215","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0220","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0225","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0235","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0245","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0250","doi-asserted-by":"crossref","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0255","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1210\/jc.2013-1115","article-title":"Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study","volume":"98","author":"Massicotte","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0260","doi-asserted-by":"crossref","first-page":"e79603","DOI":"10.1371\/journal.pone.0079603","article-title":"Pharmacokinetics of drugs in cachectic patients: a systematic review","volume":"8","author":"Trobec","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00003088-199426040-00005","article-title":"Lean body mass as a predictor of drug dosage. Implications for drug therapy","volume":"26","author":"Morgan DJ1","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0340","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2125.1998.00812.x","article-title":"Relationships among liver and kidney volumes, lean body mass and drug clearance","volume":"46","author":"Nawaratne","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0275","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/BJN20061943","article-title":"Sarcopenia is predictive of nosocomial infection in care of the elderly","volume":"96","author":"Cosqu\u00e9ric","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0285","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase\u00a0I trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","article-title":"Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy","volume":"23","author":"Jung","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0300","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000061","article-title":"Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib","author":"Cushen","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","article-title":"Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for esophagogastric cancer","volume":"41","author":"Tan","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0310","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/bjc.2011.507","article-title":"Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib","volume":"105","author":"Di Fiore","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0315","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0345","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cam4.621","article-title":"Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens","volume":"5","author":"Ali","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.07.001","article-title":"Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer","volume":"90","author":"Sj\u00f8blom","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0330","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19841115)54:10<2268::AID-CNCR2820541034>3.0.CO;2-2","article-title":"Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics","volume":"54","author":"Mihranian","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0335","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1002\/1097-0142(19931215)72:12<3715::AID-CNCR2820721225>3.0.CO;2-W","article-title":"The effect of dietary protein depletion on hepatic 5-fluorouracil metabolism","volume":"72","author":"Davis","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.04.002_bib0170","first-page":"705","article-title":"Effect of a high-protein-low-carbohydrate diet on toxicity and antitumor activity of 5-fluorouracil in mice","volume":"74","author":"Flanigen-Roat","year":"1985","journal-title":"J Natl Cancer Inst"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116300406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116300406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:26:38Z","timestamp":1536711998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455116300406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0007455116300406"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.04.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cons\u00e9quences de la diminution de la masse musculaire sur la tol\u00e9rance des traitements anticanc\u00e9reux","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}